Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Nuwellis (CHFS) Competitors

Nuwellis logo

CHFS vs. QTI, NRXS, VRAYQ, VIVE, ELMD, NTRB, ADAG, HOWL, CRDL, and IMUX

Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include QT Imaging (QTI), NeurAxis (NRXS), ViewRay (VRAYQ), Viveve Medical (VIVE), Electromed (ELMD), Nutriband (NTRB), Adagene (ADAG), Werewolf Therapeutics (HOWL), Cardiol Therapeutics (CRDL), and Immunic (IMUX). These companies are all part of the "medical" sector.

Nuwellis vs. Its Competitors

QT Imaging (NASDAQ:QTI) and Nuwellis (NASDAQ:CHFS) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment.

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 65.1% of Nuwellis shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by insiders. Comparatively, 0.6% of Nuwellis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

QT Imaging has higher earnings, but lower revenue than Nuwellis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$4.00M15.28-$4.03MN/AN/A
Nuwellis$5.51M3.75-$18.11M-$279.28-0.01

QT Imaging has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.

QT Imaging has a net margin of 0.00% compared to Nuwellis' net margin of -254.26%. QT Imaging's return on equity of 0.00% beat Nuwellis' return on equity.

Company Net Margins Return on Equity Return on Assets
QT ImagingN/A N/A -65.94%
Nuwellis -254.26%-173.61%-131.01%

In the previous week, QT Imaging's average media sentiment score of 1.61 beat Nuwellis' score of 0.00 indicating that QT Imaging is being referred to more favorably in the media.

Company Overall Sentiment
QT Imaging Very Positive
Nuwellis Neutral

Summary

QT Imaging beats Nuwellis on 7 of the 10 factors compared between the two stocks.

Get Nuwellis News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHFS vs. The Competition

MetricNuwellisElectromedical Equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$20.65M$41.24M$6.05B$10.30B
Dividend YieldN/AN/A5.73%4.82%
P/E Ratio-0.073.6585.3127.10
Price / Sales3.75209.64601.46133.24
Price / CashN/A41.3625.7730.18
Price / Book0.272.6712.676.69
Net Income-$18.11M-$2.66M$3.32B$276.55M

Nuwellis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHFS
Nuwellis
N/A$3.42
-2.3%
N/A+110.2%$20.65M$5.51M-0.0766
QTI
QT Imaging
N/A$2.39
+2.5%
N/A+300.7%$64.85M$4.00M0.00N/APositive News
NRXS
NeurAxis
1.895 of 5 stars
$3.01
-4.6%
$7.00
+132.9%
+9.6%$29.67M$3.22M-1.6319
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21M0.00300
VIVE
Viveve Medical
N/A$0.00
-50.0%
N/A-75.0%$1K$6.83M0.0070Gap Down
ELMD
Electromed
3.921 of 5 stars
$24.64
-0.5%
$36.25
+47.1%
+8.3%$206.39M$64M32.85160
NTRB
Nutriband
2.224 of 5 stars
$7.84
flat
$13.00
+65.8%
-7.2%$94.35M$2.14M-2.7310Gap Down
ADAG
Adagene
2.4836 of 5 stars
$1.99
flat
$7.00
+251.8%
-9.9%$93.79M$100K0.00260
HOWL
Werewolf Therapeutics
3.6734 of 5 stars
$1.93
-4.9%
$8.00
+314.5%
-18.5%$92.83M$1.88M-1.1840
CRDL
Cardiol Therapeutics
3.0668 of 5 stars
$1.06
-1.9%
$8.00
+654.7%
-44.1%$92.82MN/A-3.1220
IMUX
Immunic
2.2106 of 5 stars
$0.88
-6.4%
$9.50
+979.5%
-36.1%$92.73MN/A-0.9470

Related Companies and Tools


This page (NASDAQ:CHFS) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners